Terrapinn is organizing the World Drug Repositioning Congress – Europe in London, UK on 11-13 September 2012.
The event is co-located with the World Biosimilar Congress in Jumeirah Carlton Tower Hotel in London.
The 2012 World Drug Repositioning Congress is Europe’s first commercially orientated conference that provides key technical and strategic solutions to challenges faced when adopting drug repositioning into your R&D efforts.
The World Drug Repositioning Congress Europe is where decision-makers from the wider biopharmaceutical industry and service providers meet to determine best practice for drug repositioning and learn how to successfully bridge the innovation deficit through drug repositioning.
If you are interested, the website of the congress is: www.terrapinn.com/conference/drug-repositioning
Biosimilar News subscribers will get an exclusive 15% discount; to book your place contact Julia Wallace (firstname.lastname@example.org) and use voucher code QNCE